Press Releases
Rib-X Pharmaceuticals’ RX-04 Program Yields Compounds with In Vitro...
Rib-X Pharmaceuticals, Inc. announced that results from the Company's RX-04 development program will be featured today in the Novel Antimicrobial Agents poster session at...
Press Releases
Further European Regulatory Review Clarifies and Confirms Prior CHMP...
Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the European Medicines Agency (EMA)’s Committee for Medical Products for Human...
Press Releases
Cook Medical’s Zilver® PTX® Drug-Eluting Stent Technology Receives Unanimous...
The Zilver® PTX® Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA),...
Press Releases
Hybrigenics and Servier enter into a licence and research...
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, and Servier, the largest French privately-owned pharmaceutical company, announces today that they have signed...
Press Releases
Global Bio-Pharma Clinical Leaders Call for Industry Transformation at...
Clinical development, outsourcing and operations decision makers from the world’s top bio-pharmaceutical and medical device manufacturers and their clinical research partners will meet on March...
Press Releases
Genetic Technologies Limited Appoints Dr. Mervyn Cass as Company...
The Board of Directors of Genetic Technologies Limited has with great pleasure appointed Dr. Mervyn Cass as a non-executive Director of the Company. Dr. Cass...
Press Releases
IBA’s Family of Proton Beam Solutions Suits Diverse Budgets,...
IBA Particle Therapy now offers a range of Proton Therapy solutions for cancer specialty centers planning to treat from 250 to 2,000 patients annually with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.